Joseph Ssebwana Katende

6PUBLICATIONS
11CO-AUTHORS
Major global burdens of diseaseMedical virologyNanomaterialsComparative language studiesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 27, 2025
Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors of the 2000 Outbreak.

Raymond Ernest Kaweesa, Joseph Ssebwana Katende, Geoffrey Odoch

|Jul 30, 2025
Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity.

Jennifer Serwanga, Raymond Ernest Kaweesa, Joseph Katende Ssebwana

|Jun 27, 2025
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.

Jonathan Kitonsa, Jennifer Serwanga, Hannah M Cheeseman

|May 07, 2025
Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison.

Laban Kato, Jackson Sembera, Gerald Kevin Oluka

|Feb 26, 2025
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort.

Gerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende

|Jul 29, 2024
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.

Jennifer Serwanga, Gerald Kevin Oluka, Claire Baine

Pageof 1

Frequent Collaborators

2 joint publications

Jennifer Serwanga

2 joint publications

Raymond Ernest Kaweesa

2 joint publications

Ashwini Kurshan

2 joint publications

Michael H Malim